Secondary Leukemia Associated with the Anti-Cancer Agent, Etoposide, a Topoisomerase II Inhibitor-Reference-Cited by-同舟云学术

Secondary Leukemia Associated with the Anti-Cancer Agent, Etoposide, a Topoisomerase II Inhibitor

Published:2012-07-10 Issue:7 Volume:9 Page:2444-2453
ISSN:1660-4601
Container-title:International Journal of Environmental Research and Public Health
language:en
Short-container-title:IJERPH

Author:

Ezoe Sachiko

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Link

http://www.mdpi.com/1660-4601/9/7/2444/pdf

Reference55 articles.

1. Etoposide: Four decades of development of a topoisomerase II inhibitor;Hande;Eur. J. Cancer,1998

2. Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung;Ratain;Blood,1987

3. Acute myelomonocytic leukemia secondary to synchronous carcinomas of the breast and lung, and to metachronous renal cell carcinoma;Potzsch;J. Cancer Res. Clin. Oncol.,1997

4. Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: A report from the National Wilms Tumor Study Group;Shearer;J. Pediatr. Hematol. Oncol.,2001

5. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11);Domer;Leukemia,1995

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular signaling and clinical implications in the human aging-cancer cycle;Seminars in Cancer Biology;2024-11

2. Unraveling the pathogenesis of myelosuppression and therapeutic potential of natural products;Phytomedicine;2024-09

3. Hematological Second Primary Malignancy in Pediatric Retinoblastoma: A Case Report and Systematic Review;Ophthalmic Plastic & Reconstructive Surgery;2024-08-15

4. Pediatric secondary chronic myelogenous leukemia in a patient with hemophagocytic lymphohistiocytosis carrying UNC13D, LYST, and ITK variants;Pediatric Blood & Cancer;2024-07-19

5. Cancer sensitizing effect of deazaflavin analogs is associated with increased intracellular drug accumulation;European Journal of Pharmaceutical Sciences;2024-02